Table 3.
Proportion of women choosing a more effective contraceptive method, by LS, all women (total) and immigrants
| Baseline/LS1 Pre-QIC 1st Sep-12th Dec 2018 |
LS2 (13th Dec 2018-5th March 2019) |
LS3 (6th March-4th June 2019) |
LS4 (5th June-31st Aug 2019) |
Increase in more effective method in % | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Less effective/ no methodb n (%) |
More effective methodsa n (%) |
Less effective/ No methodb n (%) |
More effective methodsa n (%) |
Less effective/ no methodb n (%) |
More effective methodsa n (%) |
Less effective/ no methodb n (%) |
More effective methodsa n (%) |
LS4 vs. LS1 | LS3 vs. LS1 | LS2 vs. LS1 | |
| Immigrants | 51 (70) | 22 (30) | 30 (48) | 33 (52) | 34 (45) | 41 (55) | 45 (53) | 40 (47) | + 16.9 (0.03)c | + 24.5 | + 22.2 |
| TOTAL | 98 (64) | 55 (36) | 49 (45) | 59 (55) | 66 (46) | 78 (54) | 80 (49) | 82 (51) | + 14.7 (0.008)c | + 18.2 | + 18.7 |
aMore effective contraception was defined as short-acting reversible contraception (SARC), including contraceptive pills, the combined hormonal contraceptive patch and ring, progestin only injectables and long-acting reversible contraception (LARC), including subdermal implant, intrauterine devices and levonorgestrel intrauterine systems. bLess effective methods were defined as a choice of methods such as barrier methods, withdrawal, natural family planning or choice of no method at all
cChi2-test was used to calculate p-values regarding the difference in choice of more effective contraceptive method between LS 4 and 1
LS learning seminars, QIC Quality improvement collaborative